an example of wrong path: drug discovery today
as well as inverse genetics found the
shortest way to results
Basic
Scientists request a more rational approach than an inverse criterion to those
delicate fields
Alan Wise, Katy Gearing and Stephen Rees,Target validation of
G-protein coupled receptors Drug
Discovery Today 7, 4, 235-246,
2002
G-protein
coupled receptors (GPCRs) represent possibly the most important target class of
proteins for drug discovery. Over 30% of clinically marketed drugs are active
at this receptor family. These drugs exhibit their activity at <10% of all
known GPCRs. A major challenge for the pharmaceutical industry is to associate
the many novel GPCRs with disease to identify the drugs of the future. This
process consists of a collection of experimental paradigms that together can be
loosely labelled 'target validation'.
BM&L-March
2003